Background & Aims The occurrence of HBV-associated liver complications is reduced by
antiviral therapy. However, prior studies using local institutional cohorts have suggested that …

Chronic hepatitis B virus (HBV) infection can cause cirrhosis, liver failure, hepatocellular
carcinoma (HCC), and death. Worldwide, approximately 257 million people are chronically …

It is important to examine the effectiveness of current therapies for chronic hepatitis B in
clinical practice, given the therapeutic advances over the past 15 years. A 2010 Institute of …

Guidelines in November 2011, and published the Guidelines for the Management of
Hepatitis C in May 2012 (English version, Jan 2013). Thence the Committee decided our …

BACKGROUND & AIMS: The relative efficacies of licensed antiviral therapies for treatment-
naive chronic hepatitis B (CHB) infection in randomized controlled trials have not been …

A<fc>ASLD</fc> guidelines for treatment of chronic hepatitis <fc>B</fc> Page 1 PRACTICE
GUIDELINE AASLD Guidelines for Treatment of Chronic Hepatitis B Norah A. Terrault,1 Natalie …

Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

The Drafting Committee for Hepatitis Management Guidelines established by the Japan
Society of Hepatology published the first version of the Guidelines for the Management of …

Seven drugs have been approved for the treatment of chronic hepatitis B. Antiviral treatment
has been shown to be effective in suppressing hepatitis B virus replication, decreasing …

Hepatitis B virus (HBV) infection is an important public health problem in Canada. In keeping
with evolving evidence and understanding of HBV pathogenesis, the Canadian Association …